Articles related to DRUG SAFETY & INTERACTIONS

As healthcare professionals, it’s crucial to understand that PDE5 inhibitors, commonly prescribed for erectile dysfunction and pulmonary arterial hypertension, have been linked to retinal and vision changes. This highlights the importance of monitoring patients on these medications closely.

Did you know that recent court decisions could impact how we learn about drug risks? For instance, lecanemab (Leqembi), a new treatment for Alzheimer’s disease, has potential risks that are not fully disclosed in its label.

New research indicates that coffee can interact with certain medications including ephedrine, antidiabetic drugs, theophylline, and phenothiazines.

This study highlights a potential risk associated with benzodiazepine treatment in high-risk individuals. Learn more about how this could impact your practice.

Discover the emerging evidence on the cancer risks associated with commonly prescribed medications and what it means for your prescribing habits.

A recent study found that patients who used proton pump inhibitors (PPIs) for more than 4.4 years had a 33% higher risk of developing dementia during the follow-up period.